Table 3.
Outcome Measures Assessing the Quality of Clinical Care Delivered to 45 Diabetes Mellitus Type 2 Patients at the Shade Tree Clinic Relative To Best-Practice Benchmarks, 2008-2011
| Outcome measure | No. (% of 45) meeting ADA benchmark at T-1 |
|---|---|
| Glycosylated hemoglobin A1c (%) | |
| < 6.5 (ADA goal) | 10 (22.2) |
| < 7 | 7 (15.6) |
| < 8 | 11 (24.4) |
| < 9 | 5 (11.1) |
| ≥ 9 | 12 (26.7) |
| LDL (mg/dL)a | |
| < 100 (ADA goal) | 12 (41.4) |
| ≥ 100 | 17 (58.6) |
| Blood pressure (mmHg) | |
| < 130/80 (ADA goal) | 9 (20.0) |
| < 140/90 | 14 (31.1) |
| ≥ 140/90 | 22 (48.9) |
Note: ADA indicates American Diabetes Association; T-1, 12 ± 3 months after patient's initial presentation to the clinic.
a
Although overall we reviewed data from 45 patients, we reviewed LDL measurements from only 29 patients because the other 16 did not receive an LDL measurement within our window of 12 ± 3 months after initial presentation to the clinic.